PIM1 and cancer: Interestingly, in the good agreement with above-mentioned prediction (Figure 1C), we found that p-Bad and Hsp90 were both decreased in PI003-treated HeLa cells, indicating that PI003 may be targeting PIM1/2/3-p-Bad/Hsp30 pathway in cancer cells.